CDKN2A and chondrosarcoma: We previously published three chondrosarcoma cell lines to be negative for p16 using western blot [18] and upon overexpression of p16 using lentiviral vectors the metabolic activity and cell viability of these cell lines was decreased, indicating loss of p16 to play a role in the proliferative capacity of chondrosarcoma cells.